INKON Life Technology Co., Ltd. (SHE:300143)
China · Delayed Price · Currency is CNY 7.06
-0.18 (-2.49%)
At close: Nov 13, 2026
INKON Life Technology Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,061 | 1,886 | 1,559 | 1,471 | 1,156 | 1,090 |
Revenue Growth | 22.00% | 20.93% | 6.01% | 27.21% | 6.09% | 5.93% |
Gross Profit Gross Profit Growth | 569.88 | 504.99 | 396.59 | 410.73 | 304.1 | 259.77 |
Operating Income Operating Income Growth | 246.94 | 202.27 | 117.69 | 139.69 | 104.38 | 69.15 |
Net Income Net Income Growth | 83.7 | 68.54 | 115.42 | 100.44 | -595.92 | -364.08 |
Earnings Per Share EPS Growth | 0.08 | 0.07 | 0.14 | 0.12 | -0.78 | -0.44 |
EPS Growth | -33.79% | -50.04% | 12.51% | - | - | - |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medical Devices Division Medical Devices Division Growth | 384.14 | 366.93 | 321.73 | 159.52 | 61.84 |
Medical Service Medical Service Growth | 1,501 | 1,192 | 1,149 | 996.73 | 1,028 |
Total Total Growth | 1,886 | 1,559 | 1,471 | 1,156 | 1,090 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,074 | 1,283 | 1,367 | 519.77 | 433.18 | 661.55 |
Total Debt Total Debt Growth | 805.2 | 763.14 | 336.48 | 298.96 | 114.54 | 210.3 |
Net Cash (Debt) Net Cash Growth | 269.21 | 520.16 | 1,030 | 220.81 | 318.64 | 451.25 |
Net Cash Growth | -26.82% | -49.50% | 366.52% | -30.70% | -29.39% | -27.72% |
Net Cash Per Share Net Cash Per Share Growth | 0.27 | 0.53 | 1.24 | 0.27 | 0.42 | 0.54 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 494.97 | 340.83 | 259.25 | 190.01 | 160.67 | 125.61 |
Capital Expenditures CapEx Growth | -155.51 | -226.64 | -198.67 | -158.2 | -125.38 | -56.33 |
Free Cash Flow Free Cash Flow Growth | 339.46 | 114.19 | 60.58 | 31.81 | 35.29 | 69.29 |
Free Cash Flow Growth | 1000.57% | 88.49% | 90.46% | -9.87% | -49.07% | 215.72% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 27.65% | 26.78% | 25.44% | 27.93% | 26.30% | 23.84% |
Operating Margin | 11.98% | 10.73% | 7.55% | 9.50% | 9.03% | 6.35% |
Pretax Margin | 9.08% | 8.04% | 9.57% | 8.94% | -48.88% | -29.78% |
Profit Margin | 4.06% | 3.64% | 7.40% | 6.83% | -51.54% | -33.41% |
FCF Margin | 16.47% | 6.06% | 3.89% | 2.16% | 3.05% | 6.36% |
Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.019 | 0.019 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.27% | 0.25% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 83.65 | 107.14 | 59.05 | 67.70 | - | - |
Forward PE | - | 46.77 | 38.13 | 44.79 | 41.51 | 40.92 |
P/FCF Ratio | 20.12 | 64.31 | 112.50 | 213.77 | 184.33 | 130.35 |
PS Ratio | 3.31 | 3.90 | 4.37 | 4.62 | 5.63 | 8.29 |